X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (747) 747
Book Review (87) 87
Publication (83) 83
Conference Proceeding (20) 20
Book / eBook (15) 15
Book Chapter (8) 8
Magazine Article (5) 5
Newsletter (4) 4
Dissertation (3) 3
Newspaper Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (427) 427
humans (327) 327
male (213) 213
female (208) 208
middle aged (141) 141
adult (124) 124
aged (119) 119
animals (103) 103
research (92) 92
analysis (86) 86
surgery (75) 75
risk factors (71) 71
medicine & public health (63) 63
oncology (57) 57
health aspects (52) 52
research article (46) 46
abridged index medicus (45) 45
cancer (45) 45
medicine, general & internal (44) 44
urology & nephrology (44) 44
aged, 80 and over (43) 43
medicine (42) 42
prevalence (41) 41
mice (40) 40
mortality (38) 38
astronomy & astrophysics (37) 37
disease (36) 36
physiology (35) 35
studies (34) 34
cardiac & cardiovascular systems (33) 33
care and treatment (33) 33
multidisciplinary sciences (33) 33
risk (33) 33
treatment outcome (33) 33
patients (32) 32
adolescent (31) 31
gastroenterology & hepatology (31) 31
neurosciences (31) 31
proteins (31) 31
time factors (30) 30
inflammation (28) 28
mars (28) 28
transplantation (28) 28
gene expression (27) 27
genetic aspects (27) 27
article (26) 26
diagnosis (26) 26
prospective studies (26) 26
rats (26) 26
cell biology (25) 25
population (25) 25
retrospective studies (25) 25
surveys and questionnaires (25) 25
usage (25) 25
expression (24) 24
immunology (24) 24
science (24) 24
women (24) 24
exercise (23) 23
survival (23) 23
young adult (23) 23
depression (22) 22
nephrology (22) 22
oxidative stress (22) 22
prognosis (22) 22
cross-sectional studies (21) 21
follow-up studies (21) 21
medical research (21) 21
pathology (21) 21
physiological aspects (21) 21
cardiovascular diseases (20) 20
clinical neurology (20) 20
diabetes (20) 20
quality-of-life (20) 20
hematology (19) 19
pharmacology & pharmacy (19) 19
psychiatry (19) 19
cells (18) 18
drug therapy (18) 18
epidemiology (18) 18
evolution (18) 18
kidney diseases (18) 18
properties (18) 18
quality of life (18) 18
rodents (18) 18
infection (17) 17
infectious diseases (17) 17
kidney - pathology (17) 17
observations (17) 17
cardiovascular disease (16) 16
development and progression (16) 16
disease models, animal (16) 16
follow-up (16) 16
heme oxygenase-1 (16) 16
infections (16) 16
multivariate analysis (16) 16
orthopedics (16) 16
public, environmental & occupational health (16) 16
radiology, nuclear medicine & medical imaging (16) 16
stem cells (16) 16
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (5) 5
UTL at Downsview - May be requested (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Online Resources - Online (2) 2
Robarts - Stacks (2) 2
Thomas Fisher Rare Book - Rare Book (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Music - Stacks (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Trinity College (John W Graham) - Storage (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 25, pp. 2387 - 2397
In this trial, patients with an acute coronary syndrome within the previous 10 days were randomly assigned to simvastatin plus either ezetimibe or placebo. At... 
CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Liver | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
by Aihara, Hiroaki and Allende Prieto, Carlos and An, Deokkeun and Anderson, Scott F and Aubourg, Éric and Balbinot, Eduardo and Beers, Timothy C and Berlind, Andreas A and Bickerton, Steven J and Bizyaev, Dmitry and Blanton, Michael R and Bochanski, John J and Bolton, Adam S and Bovy, Jo and Brandt, W. N and Brinkmann, J and Brown, Peter J and Brownstein, Joel R and Busca, Nicolas G and Campbell, Heather and Carr, Michael A and Chen, Yanmei and Chiappini, Cristina and Comparat, Johan and Connolly, Natalia and Cortes, Marina and Croft, Rupert A. C and Cuesta, Antonio J and da Costa, Luiz N and Davenport, James R. A and Dawson, Kyle and Dhital, Saurav and Ealet, Anne and Ebelke, Garrett L and Edmondson, Edward M and Eisenstein, Daniel J and Escoffier, Stephanie and Esposito, Massimiliano and Evans, Michael L and Fan, Xiaohui and Femenía Castellá, Bruno and Font-Ribera, Andreu and Frinchaboy, Peter M and Ge, Jian and Gillespie, Bruce A and Gilmore, G and González Hernández, Jonay I and Gott, J. Richard and Gould, Andrew and Grebel, Eva K and Gunn, James E and Hamilton, Jean-Christophe and Harding, Paul and Harris, David W and Hawley, Suzanne L and Hearty, Frederick R and Ho, Shirley and Hogg, David W and Holtzman, Jon A and Honscheid, Klaus and Inada, Naohisa and Ivans, Inese I and Jiang, Linhua and Johnson, Jennifer A and Jordan, Cathy and Jordan, Wendell P and Kazin, Eyal A and Kirkby, David and Klaene, Mark A and Knapp, G. R and Kneib, Jean-Paul and Kochanek, C. S and Koesterke, Lars and Kollmeier, Juna A and Kron, Richard G and Lampeitl, Hubert and Lang, Dustin and Le Goff, Jean-Marc and Lee, Young Sun and Lin, Yen-Ting and Long, Daniel C and Loomis, Craig P and Lucatello, Sara and Lundgren, Britt and Lupton, Robert H and Ma, Zhibo and MacDonald, Nicholas and Mahadevan, Suvrath and Maia, Marcio A. G and Makler, Martin and Malanushenko, Elena and Malanushenko, Viktor and Mandelbaum, Rachel and Maraston, Claudia and Margala, Daniel and Masters, Karen L and McBride, Cameron K and McGehee, Peregrine M and McGreer, Ian D and Ménard, Brice and ... and Fermi National Accelerator Lab. (FNAL), Batavia, IL (United States)
The Astrophysical Journal Supplement Series, ISSN 0067-0049, 04/2011, Volume 193, Issue 2, p. 29
Journal Article
by White, Harvey D and Held, Claes and Stewart, Ralph and Tarka, Elizabeth and Brown, Rebekkah and Davies, Richard Y and Budaj, Anzej and Harrington, Robert A and Steg, P. Gabriel and Ardissino, Diego and Armstrong, Paul W and Avezum, Alvaro and Aylward, Philip E and Bryce, Alfonso and Chen, Hong and Chen, Ming-Fong and Corbalan, Ramon and Dalby, Anthony J and Danchin, Nicolas and de Winter, Robbert J and Denchev, Stefan and Diaz, Rafael and Elisaf, Moses and Flather, Marcus D and Goudev, Assen R and Granger, Christopher B and Grinfeld, Liliana and Hochman, Judith S and Husted, Steen and Kim, Hyo-Soo and Koenig, Wolfgang and Linhart, Ales and Lonn, Eva and López-Sendón, José and Manolis, Athanasios J and Mohler, Emile R and Nicolau, José C and Pais, Prem and Parkhomenko, Alexander and Pedersen, Terje R and Pella, Daniel and Ramos-Corrales, Marco A and Ruda, Mikhail and Sereg, Mátyás and Siddique, Saulat and Sinnaeve, Peter and Smith, Peter and Sritara, Piyamitr and Swart, Henk P and Sy, Rody G and Teramoto, Tamio and Tse, Hung-Fat and Watson, David and Weaver, W. Douglas and Weiss, Robert and Viigimaa, Margus and Vinereanu, gos and Zhu, Junren and Cannon, Christopher P and Wallentin, Lars and Steg, Ph Gabriel and Bucan, Olga and Elfström, Charlotta and Hegg, Lisa and Jarosz, Marie and Krug-Gourley, Sue and Rudman, Jerry and Collins, Rory and Anderson, Jeffrey and DeMets, David and Ganz, Peter and Sandercock, Peter and Weber, Michael and Fisher, Marian and Buhr, Kevin and Diegel, Scott and Schultz, Melissa and Mahaffey, Kenneth W and Alexander, John H and Al-Khatib, Sana and Baron, Tomasz and Bergström, Olle and Bushnell, Cheryl and Christersson, Christina and Eggers, Kai and Fredlund, Bengt-Olov and Hagström, Emil and Hijazi, Ziad and Örndahl, Lovisa Holm and James, Stefan K and Jernberg, Tomas and Johnston, Nina and Lopez, Renato D and Mehta, Rajena H and Newby, Kristin L and Nordmark, Örjan and Oldgren, Jonas and Roe, Matthew T and Saldéen, Katarina and Stenborg, Anna and ... and The STABILITY Investigators and STABILITY Investigators and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Kardiologi and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Uppsala universitet and Institutionen för medicinska vetenskaper and Uppsala kliniska forskningscentrum (UCR)
The New England Journal of Medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 18, pp. 1702 - 1711
Darapladib, an oral inhibitor of lipoprotein-associated phospholipase A2, was compared with placebo in 15,828 patients with stable coronary heart disease.... 
TRIAL | LIPOPROTEIN | MEDICINE, GENERAL & INTERNAL | THERAPY | ACTIVATING-FACTOR ACETYLHYDROLASE | OXIDIZED LDL | RISK | PHOSPHOLIPASE A | ATHEROSCLEROTIC PLAQUE | INHIBITOR | CLINICAL-OUTCOMES | Stroke - prevention & control | Double-Blind Method | Follow-Up Studies | Oximes - adverse effects | Phospholipase A2 Inhibitors - administration & dosage | Humans | Middle Aged | Kaplan-Meier Estimate | Oximes - administration & dosage | Male | Coronary Artery Disease - drug therapy | Coronary Disease - mortality | Phospholipase A2 Inhibitors - adverse effects | Benzaldehydes - adverse effects | Benzaldehydes - administration & dosage | Coronary Artery Disease - complications | Treatment Failure | Coronary Disease - drug therapy | Female | Aged | Myocardial Infarction - prevention & control | Prevention | Care and treatment | Ischemia | Dosage and administration | Research | Coronary heart disease | Cardiovascular agents | Myocardial infarction | Cerebral infarction | Phospholipase A2 | Clinical trials | Myocardial ischemia | Cardiovascular disease | Angina | Preventive medicine | Coronary artery disease | Phospholipase | Arteriosclerosis | Death | Plasma levels | Drug therapy | Heart diseases | Plaques | Index Medicus | Abridged Index Medicus | Malalties cardiovasculars | Infart de miocardi | Malalties coronàries | Assaigs clínics de medicaments | Cardiovascular diseases | Drug testing | Coronary diseases | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article